RxDoctor Payments Data

Erika Laraine Chico, MD

Family Medicine · Chicago, ILNPI 1700308640

Payments from drug & device makers

$3,746in general payments, 2019–2025

Across 206 payments — averaging $18.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$497
  • Boehringer Ingelheim$480
  • AstraZeneca$409
  • Novo Nordisk$347
  • Lilly USA, LLC$301
  • Amgen$274
  • plus $1K from 19 others

What the payments were for

  • Food & beverage$3,746100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,746 in reported general payments places this provider in the 85th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$21,914
Medicare patients
106
Services billed
248

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol165$166,244
JardianceEmpagliflozin130$164,770
JanuviaSitagliptin Phosphate53$64,833
OzempicSemaglutide39$60,244
TrulicityDulaglutide43$55,388
EliquisApixaban27$42,978
LinzessLinaclotide14$21,757
TradjentaLinagliptin16$13,355
XareltoRivaroxaban12$10,327
Janumet XrSitagliptin Phos/Metformin Hcl13$8,136
Humulin 70/30 KwikpenInsulin Nph Hum/Reg Insulin Hm18$5,933
SymbicortBudesonide/Formoterol Fumarate11$5,523
Lantus SolostarInsulin Glargine,hum.Rec.Anlog37$3,918
Valsartan68$3,726
Atorvastatin Calcium364$3,490

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$480$178,126146 claims
AstraZenecaFarxiga, Symbicort$409$171,767176 claims
MerckJanuvia, Janumet Xr$103$72,96966 claims
Novo NordiskOzempic$347$60,24439 claims
Lilly USA, LLCTrulicity$301$55,38843 claims
PfizerEliquis$240$42,97827 claims
AbbVieLinzess$497$21,75714 claims
Johnson & JohnsonXarelto$47$10,32712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →